AMBERLEIGH MORRISH: Open Payments
NPI 1467065532 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 15 payments from 6 companies in 2025. Trend: 2023 $37 · 2024 $234 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $139 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Alexion Pharmaceuticals, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Travere Therapeutics, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $24 |
Products named: JARDIANCE, FARXIGA, ULTOMIRIS, Kerendia, Ozempic.
Industry payments across NM — which companies pay providers there.
